RecruitingPhase 4ACTRN12616000900415

Pain treatment after open-chest operations with three possibilities of pain-relief therapy.

The assessment of various types of perioperative analgesia after the thoracotomy.


Sponsor

Medical University of Lublin

Enrollment

120 participants

Start Date

Jul 26, 2016

Study Type

Interventional

Conditions

Summary

The main aim of the study is assessment of three types of analgesic approach in patients after thoracotomy. The secondary aim is evaluation of neurophatic pain 1, 3 and 6 months after surgery.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 75 Yearss

Inclusion Criteria1

  • Elective thoracotomy surgery

Exclusion Criteria5

  • No consent obtained
  • Coagulopathy
  • Poorly-controlled diabetes mellitus
  • Depression or other psychiatric disorders which requiered antidepressant drugs
  • Alcohol or recreational drugs addiction

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

All patients participated in the study will receive morphine in postoperative period. Pain will be measured with visual-analogue scale (VAS) during 24 hours after surgery as well as morphine consumpti

All patients participated in the study will receive morphine in postoperative period. Pain will be measured with visual-analogue scale (VAS) during 24 hours after surgery as well as morphine consumption will be noted. Morphine will be administered with patient-controlled analgesia devices (PCA). Each patient participated in the study will be aneasthetised in the same manner. Total intravenous anaesthesia approach: propofol, fentanyl, rocuronium. Other drugs (atropine, neostigmine, ondansetron) will be given as required. 30 minutes before the end of surgery, all patients will receive bolus of morphine ( 0.1-0,15 mg/kg) and 2 grams of metamizol intravenously. In postoperative period each patient will get metamizol (every 6 h). When pain increases above 40 in VAS, patients will receive 5 mg of morphine. Ondansetron will be given as required due to nausea and vomiting. Patients will be randomly assigned to one of the treated groups (i.e. contrainication to paravertebral catheter placement or allergy to any of drugs will exclude a patient from the study). First group: before the surgery paravertebral catheter will be placed. Each patient in this group will receive 30 ml of local anaesthetic solution (0,25% bupivacaine with 2 mcg of fentanyl per ml) at the end of operation. After the emergence from general anaesthesia the infusion of local anesthetic solution will be continued (0.1 ml/kg/h) for 24 h. Second group: after induction of general anaesthesia, but before the first incision, patients in this group will receive i.v. injection of ketamine (1 mg/kg) Third group (control group): only morphine and metamizol will be given in postoperative period as pain-relief drugs (standard care). 1,2 and 6 months after the surgery neuropathic pain will be assesed. Each patient participated in the study will be called and NPSI (Neuropathic Pain Symptom Inventory) will be used to measure pain.


Locations(1)

Poland

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12616000900415


Related Trials